Potency Trends of Δ 9 ‐THC and Other Cannabinoids in Confiscated Cannabis Preparations from 1993 to 2008*

Outliers in Statistical Data

BARNETT, V. D., Lewis, T., & Abeles, F. F. (1979) · Physics Today · doi:10.1063/1.2995737 · Cited by 2,834 · see citing works

The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9 ‐tetrahydrocannabinol, cannabidiol and Δ 9 ‐tetrahydrocannabivarin

Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 1,953 · see citing works

Outliers in Statistical Data.

Balakrishnan, N., Barnett, V., & Lewis, T. (1995) · Biometrics · doi:10.2307/2533352 · Cited by 1,228 · see citing works

Chemical constituents of marijuana: The complex mixture of natural cannabinoids

ElSohly, M. A., & Slade, D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.011 · Cited by 1,094 · see citing works

History of cannabis as a medicine: a review.

Zuardi, A. (2006) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462006000200015 · Cited by 581 · see citing works

Cannabidiol—recent advances

Mechoulam, R., Peters, M., Murillo‐Rodriguez, E., & Hanuš, L. O. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790147 · Cited by 515 · see citing works

High-Potency Marijuana Impairs Executive Function and Inhibitory Motor Control

Ramaekers, J. G., Kauert, G., van Ruitenbeek, P., Theunissen, E. L., Schneider, E., & Moeller, M. R. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301068 · Cited by 397 · see citing works

Potency Trends of Δ9-THC and Other Cannabinoids in Confiscated Marijuana from 1980–1997

ElSohly, M., Ross, S. A., Mehmedic, Z., Arafat, R., Yi, B., & Banahan, B. (2000) · Journal of Forensic Sciences · doi:10.1520/jfs14636j · Cited by 309 · see citing works

Potency of Δ9–THC and Other Cannabinoids in Cannabis in England in 2005: Implications for Psychoactivity and Pharmacology*

Potter, D. J., Clark, P., & Brown, M. B. (2008) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2007.00603.x · Cited by 230 · see citing works

Cannabis potency and contamination: a review of the literature

McLaren, J., Swift, W., Dillon, P., & ALLSOP, S. J. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02230.x · Cited by 212 · see citing works

Biologically Active Cannabinoids from High-Potency <i>Cannabis sativa</i>

Radwan, M. M., ElSohly, M. A., Slade, D., Ahmed, S. A., Khan, I. A., & Ross, S. A. (2009) · Journal of Natural Products · doi:10.1021/np900067k · Cited by 185 · see citing works

Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops

Buisman‐Pijlman, F. T. A., Rigter, S., Hoek, J. A., Goldschmidt, H., & Niesink, R. J. M. (2005) · Addiction Biology · doi:10.1080/13556210500123217 · Cited by 168 · see citing works

Time course of cannabinoid accumulation and chemotype development during the growth of Cannabis sativa L.

Pacifico, D., Miselli, F., Carboni, A., Moschella, A., & Mandolino, G. (2008) · Euphytica · doi:10.1007/s10681-007-9543-y · Cited by 147 · see citing works

Non-cannabinoid constituents from a high potency Cannabis sativa variety

Radwan, M. M., ElSohly, M. A., Slade, D., Ahmed, S. A., Wilson, L., El‐Alfy, A. T., Khan, I. A., & Ross, S. A. (2008) · Phytochemistry · doi:10.1016/j.phytochem.2008.07.010 · Cited by 135 · see citing works

Cannabinoid Ester Constituents from High-PotencyCannabis sativa

Ahmed, S. A., Ross, S. A., Slade, D., Radwan, M. M., Zulfiqar, F., & ElSohly, M. A. (2008) · Journal of Natural Products · doi:10.1021/np070454a · Cited by 121 · see citing works

Isolation and Characterization of New Cannabis Constituents from a High Potency Variety

Radwan, M. M., Ross, S. A., Slade, D., Ahmed, S. A., Zulfiqar, F., & ElSohly, M. A. (2008) · Planta Medica · doi:10.1055/s-2008-1034311 · Cited by 115 · see citing works

Genetics and Marker-assisted Selection of the Chemotype in Cannabis sativa L.

Pacifico, D., Miselli, F., Micheler, M., Carboni, A., Ranalli, P., & Mandolino, G. (2006) · Molecular Breeding · doi:10.1007/s11032-005-5681-x · Cited by 109 · see citing works

The THC content of cannabis in Australia: evidence and implications

Hall, W., & Swift, W. (2000) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.2000.tb00500.x · Cited by 69 · see citing works

9-Tetrahydrocannabivarin as a Marker for the Ingestion of Marijuana versus Marinol(R): Results of a Clinical Study

ElSohly, M. A., deWit, H., Wachtel, S. R., Feng, S., & Murphy, T. P. (2001) · Journal of Analytical Toxicology · doi:10.1093/jat/25.7.565 · Cited by 63 · see citing works

Structure determination and absolute configuration of cannabichromanone derivatives from high potency Cannabis sativa

Ahmed, S. A., Ross, S. A., Slade, D., Radwan, M. M., Khan, I. A., & ElSohly, M. A. (2008) · Tetrahedron Letters · doi:10.1016/j.tetlet.2008.07.178 · Cited by 54 · see citing works

Effect of nitrogen on tetrahydrocannabinol (THC) content in hemp (Cannabis sativa L.) leaves at different positions

Bócsa, I., Máthé, P., & Hangyel, L. (1997) · Cited by 50 · see citing works

An Overview of Cannabis Potency in Europe

King, L. A. (2005) · Cited by 46 · see citing works

Naturally Occurring and Related Synthetic Cannabinoids and their Potential Therapeutic Applications

Galal, A. M., Slade, D., Gul, W., El‐Alfy, A. T., Ferreira, D., & ElSohly, M. A. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909788453031 · Cited by 44 · see citing works

Cannabis potency in Europe

King, L. A., Carpentier, C., & Griffiths, P. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.001137.x · Cited by 43 · see citing works

Δ9-Tetrahydrocannabinol Content of Commercially Available Hemp Products*

Holler, J. M., Bosy, T. Z., Dunkley, C. S., et al. (2008) · Journal of Analytical Toxicology · doi:10.1093/jat/32.6.428 · Cited by 43 · see citing works

HIGH POTENCY CANNABIS: THE FORGOTTEN VARIABLE

Smith, N. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01295.x · Cited by 35 · see citing works

CBN and D9-THC concentration ratio as an indicator of the age of stored marijuana samples*

Ross, S. A., & ElSohly, M. A. (1997) · Boletín de estupefacientes · Cited by 32 · see citing works

A Polar Cannabinoid from Cannabis Sativa Var. Carma

Appendino, G., Giana, A., Gibbons, S., Maffei, M. E., Gnavi, G., Grassi, G., & Sterner, O. (2008) · Natural Product Communications · doi:10.1177/1934578x0800301207 · Cited by 26 · see citing works

Distribution of the principal cannabinoids within bars of compressed cannabis resin

Lewis, R., Ward, S. E., Johnson, R., et al. (2005) · Analytica Chimica Acta · doi:10.1016/j.aca.2005.02.014 · Cited by 26 · see citing works

Cannabinoid contents in cannabis products seized in São Paulo, Brazil, 2006–2007

Oliveira, G. L., Voloch, M. H., Sztulman, G. B., et al. (2008) · Forensic Toxicology · doi:10.1007/s11419-008-0046-x · Cited by 23 · see citing works

Delta9 THC content in illicit cannabis products over the period 1997-2004 (first four months).

Licata, M., Verri, P., & Beduschi, G. (2005) · PubMed · Cited by 23 · see citing works

The potency of cannabis in New Zealand from 1976 to 1996

Poulsen, H., & Sutherland, G. J. (2000) · Science & Justice · doi:10.1016/s1355-0306(00)71972-1 · Cited by 22 · see citing works

Understanding Cannabinoid Psychoactivity with Mouse Genetic Models

Mackie, K. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050280 · Cited by 18 · see citing works

Δ9-Tetrahydrocannabivarin (Δ9-THCV) as a Marker for the Ingestion of Cannabis versus Marinol®

ElSohly, M. A., Feng, S., Murphy, T. P., Ross, S. A., Nimrod, A. C., Mehmedic, Z., & Fortner, N. A. (1999) · Journal of Analytical Toxicology · doi:10.1093/jat/23.3.222 · Cited by 18 · see citing works

Constituents of Cannabis sativa L. XXIV: The Potency of Confiscated Marijuana, Hashish, and Hash Oil Over a Ten-Year Period

ElSohly, M., Holley, J., Gs, L., et al. (1984) · Journal of Forensic Sciences · doi:10.1520/jfs11698j · Cited by 16 · see citing works

From Active Ingredients to the Discovery of the Targets: The Cannabinoid Receptors

Mackie, K. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790148 · Cited by 15 · see citing works

Medical marijuana: politics trumps science at the FDA.

Carter, G. T., & MIRKEN, B. (2006) · PubMed · Cited by 5 · see citing works

Cannabis and cancer link

Swami, M. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2617 · Cited by 3 · see citing works

Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013.

Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1858 · Cited by 1,086 · see citing works

Practical considerations in medical cannabis administration and dosing

MacCallum, C. A., & Russo, E. B. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.01.004 · Cited by 663 · see citing works

Safety and side effects of cannabidiol, a Cannabis sativa constituent

Machado Bergamaschi, M., Helena Costa Queiroz, R., Waldo Zuardi, A., & Alexandre S. Crippa, J. (2011) · Current Drug Safety · doi:10.2174/157488611798280924 · Cited by 558 · see citing works

Association Between Cannabis and Psychosis: Epidemiologic Evidence

Gage, S. H., Hickman, M., & Zammit, S. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.001 · Cited by 379 · see citing works

Challenges towards revitalizing hemp: A multifaceted crop

Schluttenhofer, C., & Yuan, L. (2017) · Trends in Plant Science · doi:10.1016/j.tplants.2017.08.004 · Cited by 348 · see citing works

Phytocannabinoids as novel therapeutic agents in {CNS} disorders.

Hill, A. J., Williams, C. M., Whalley, B. J., & Stephens, G. J. (2012) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2011.09.002 · Cited by 312 · see citing works

Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial

Corey-Bloom, J., Wolfson, T., Gamst, A., Jin, S., Marcotte, T. D., Bentley, H., & Gouaux, B. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.110837 · Cited by 235 · see citing works

Causal Inference in Developmental Origins of Health and Disease (DOHaD) Research

Gage, S. H., Munafò, M. R., & Davey Smith, G. (2016) · Annual Review of Psychology · doi:10.1146/annurev-psych-122414-033352 · Cited by 173 · see citing works

Persistent inhibitory circuit defects and disrupted social behaviour following in utero exogenous cannabinoid exposure

Vargish, G. A., Pelkey, K. A., Yuan, X., Chittajallu, R., Collins, D., Fang, C., & McBain, C. J. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.17 · Cited by 93 · see citing works

Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA

Chiu, V., Leung, J., Hall, W., Stjepanović, D., & Degenhardt, L. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108610 · Cited by 92 · see citing works

Functional Connectivity Disruption in Neonates with Prenatal Marijuana Exposure

Grewen, K., Salzwedel, A. P., & Gao, W. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00601 · Cited by 72 · see citing works

Marijuana use trajectories during college predict health outcomes nine years post-matriculation.

Arria, A. M., Caldeira, K. M., Bugbee, B. A., Vincent, K. B., & O’Grady, K. E. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.12.009 · Cited by 71 · see citing works

Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders

Nock, N. L., Minnes, S., & Alberts, J. L. (2017) · Birth Defects Research · doi:10.1002/bdr2.1182 · Cited by 61 · see citing works

Psychosocial and pharmacological interventions for the treatment of cannabis use disorder

Sabioni, P., & Le Foll, B. (2018) · F1000Research · doi:10.12688/f1000research.11191.1 · Cited by 37 · see citing works

Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview

Hasin, D., Shmulewitz, D., Stohl, M., Greenstein, E., Roncone, S., Aharonovich, E., & Wall, M. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108294 · Cited by 31 · see citing works

Identification in hashish of tetrahydrocannabinol, cannabidiol and cannabinol analogues with a methyl side-chain

Vree, T. B., Breimer, D. D., van Ginneken, C. A. M., & van Rossum, J. M. (1972) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1972.tb08857.x · Cited by 88 · see citing works

Extensive phytocannabinoid profiles of seized cannabis and cannabis-based medicines – Identification of potential distinguishing markers

Scheunemann, A., Elsner, K., Germerott, T., Hess, C., Zörntlein, S., & Röhrich, J. (2021) · Forensic Science International · doi:10.1016/j.forsciint.2021.110773 · Cited by 11 · see citing works

119. Cannabis indica. Part II. Isolation of cannabidiol from Egyptian hashish. Observations on the structure of cannabinol

Jacob, A. G., & Todd, A. R. (1940) · Journal of the Chemical Society (Resumed) · doi:10.1039/jr9400000649 · Cited by 55 · see citing works

Identification of Potential Distinguishing Markers for the Use of Cannabis-Based Medicines or Street Cannabis in Serum Samples

Scheunemann, A., Elsner, K., Germerott, T., Groppa, S., Heß, C., Miederer, I., Poplawski, A., & Röhrich, J. (2021) · Metabolites · doi:10.3390/metabo11050316 · Cited by 9 · see citing works

Cannabinoid bis-homologues: Miniaturised synthesis and GLC study

Crombie, L., & Crombie, W. M. L. (1975) · Phytochemistry · doi:10.1016/0031-9422(75)85042-4 · Cited by 15 · see citing works